Skip to main content
. 2020 Aug 7;12(2):266–274. doi: 10.1007/s12975-020-00839-4

Fig. 2.

Fig. 2

Cumulative incidences of outcomes after apixaban administration. a Composite event of all-cause death, ISTH major bleeding events, and recurrent ischemic events. b All-cause death. c ISTH major bleeding events. d Ischemic events